Browsing by Author "Gonzalez, G"
Now showing 1 - 4 of 4
Results Per Page
Sort Options
- ItemAssociation of primary antiphospholipid syndrome with primary adrenal insufficiency(J RHEUMATOL PUBL CO, 1996) Gonzalez, G; Gutierrez, M; Ortiz, M; Tellez, R; Figueroa, F; Jacobelli, SThe association of primary adrenal insufficiency with antiphospholipid antibodies is usually reported in the context of adrenal thrombosis or hemorrhage. We describe a 35-year-old woman who developed a primary antiphospholipid syndrome (spontaneous abortion, thrombocytopenia, and cerebrovascular occlusion) in association with primary adrenal insufficiency without evidence of suprarenal hemorrhage or thrombosis.
- ItemDynamic modelling and advanced multivariable control of conventional flotation circuits(PERGAMON-ELSEVIER SCIENCE LTD, 1998) Perez Correa, R; Gonzalez, G; Casali, A; Cipriano, A; Barrera, R; Zavala, EExpert and predictive multivariable control algorithms for a conventional cooper flotation circuit were assessed through simulations These simulations were carried out with a nonlinear dynamic model, derived from mass balances and empirical relationships, that qualitatively reproduced the dynamic behaviour of a real plant well. In order to make the simulations more realistic, they included noisy measurements, stochastic parameter variations and input disturbances. New expert algorithms were able to keep the plant operating within a pre-defined zone for long periods without complete control saturation, unlike previous expert controllers. In addition, the inclusion of constraints in a multivariable predictive algorithm verified improved control system regulation and flexibility. (C) 1998 Published by Elsevier Science Ltd. All rights reserved.
- ItemPathological characteristics of thyroid microcarcinoma. A review of 402 biopsies(2005) Fardella, C; Jimenez, M; Gonzalez, H; Leon, A; Goni, I; Cruz, F; Solar, A; Torres, J; Mosso, L; Gonzalez, G; Rodriguez, JA; Campusano, C; Lopez, JM; Arteaga, EBackground: Thyroid microcarcinoma is a tumor of 10 mm or less. that should have a low risk of mortality. However a subgroup of these carcinomas is as aggressive as bigger tumors. Aim To describe the pathological presentation of these tumors.. and compare them with larger tumors. Material and methods. All Pathological samples of thyroid carcinoma that were obtained between 1992 and 2003, were studied. In all biopsies, the pathological type, tumor size. the focal or multifocal character the presence of lymph node involvement and the presence of lymphocytic thyroiditis or thyroid hyperplasia, were recorded. Results: One hundred eighteen microcarcinomas and 284 larger tumors were studied. The mean age of patients with microcarcinoma and larger tumors was 42.7 +/- 14 and 49.3 +/- 16 years respectively (p < 0,00.1) and 83% were female. without gender differences between tumor types. klean size of microcarcinomas was 8.6 mm and 116 (98%) were papillary carcinomas. Of these. 109 (94% were well differentiated and seven (6%) were moderatly differentiated. Thirty six(31%) were multifocal and in 10 (8,6%), there was lymph node involvement. The mean size of larger tumors was 23.8 mm and 241 (85%) were papillary carcinomas. Of these, 200 (83%) were well differentiated, and 41 (17%) were moderately differentiated.Eighty five (35%) were multifocal and in 44 (18%) there was lymph node involvement. The prevalence of thyroiditis and hyperplasia was significantly higher among microcardinomas than in larger tumors (15 and 2.5%, respectively, p < 0.001, for the former; 32.4 and 1.7%, respectively, p < 0.001, for the latter. Conclusions. In this series. one third of microcarcinomas were multifocal and 10% had lymph node involvement. Therefore, aggresiveness of these tumors is higher than what is reported in the literature and they should be treated with total thyroidectomy.
- ItemSuccessful treatment of hyperthyroidism with amiodarone in a patient with propylthiouracil-induced acute hepatic failure(MARY ANN LIEBERT, INC, 2004) Brusco, F; Gonzalez, G; Soto, N; Arteaga, EAcute hepatic failure is a rare and potentially lethal complication of propylthiouracil (PTU) use for hyperthyroidism. We present a 20-year-old woman with Basedow-Graves' disease who developed PTU-induced fulminant hepatitis, which progressed to acute hepatic failure with grade III hepatic encephalopathy. Laboratory evaluation ruled out the most common causes of fulminant hepatitis. We treated her hyperthyroidism with amiodarone (average daily dose, 200 mg) for 3 weeks, achieving rapid and persistent euthyroidism, (triiodothyronine [T-3] levels ranged between 64 and 109 ng/dL) without side effects. Amiodarone treatment did not abolish the thyroid radioactive iodine uptake (RAIU), allowing for subsequent treatment with radioactive iodine. The clinical course was favorable and the patient achieved full hepatic recovery 3 months after the hepatic failure was detected. After an extensive review of the literature, we believe that this is the first communication of the successful use of amiodarone to control hyperthyroidism in a patient with PTU-induced fulminant hepatitis.